Hyperfine (HYPR) Change in Account Payables (2021 - 2026)
Hyperfine (HYPR) posted Change in Account Payables of $504000.0 for Q1 2026, up 123.74% on a QoQ basis from -$2.1 million in Q4 2025, and down 16.0% year-over-year from $600000.0 in Q1 2025.
Hyperfine (HYPR) Change in Account Payables (2021 - 2026) Analysis & Trends
Hyperfine's Change in Account Payables history runs 6 years deep, the most recent figure standing at $504000.0 for Q1 2026.
- Quarterly Change in Account Payables fell 16.0% year-over-year to $504000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$107000.0 (down 110.72% YoY) and the FY2025 annual result came in at -$11000.0, down 102.88% from the prior year.
- Change in Account Payables was $504000.0 for Q1 2026 at Hyperfine, up from -$2.1 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.1 million in Q3 2025 and bottomed at -$2.1 million in Q4 2025.
- A 5-year average of -$33705.9 and a median of $3000.0 in 2023 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 4747.37% in 2024, while the deepest fall reached 29266.67% in 2024.
- Hyperfine's Change in Account Payables stood at -$459000.0 in 2022, then surged by 205.66% to $485000.0 in 2023, then declined by 19.59% to $390000.0 in 2024, then sank by 644.36% to -$2.1 million in 2025, then soared by 123.74% to $504000.0 in 2026.
- Business Quant data shows HYPR's Change in Account Payables at $504000.0 in Q1 2026, -$2.1 million in Q4 2025, and $2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn | 504,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 504,000.00 |
| Mar 31, 2026 | 504,000.00 |
| Dec 31, 2025 | -2.12 Mn |
| Dec 31, 2025 | -2.12 Mn |
| Sep 30, 2025 | 2.11 Mn |
| Sep 30, 2025 | 2.11 Mn |
| Jun 30, 2025 | -602,000.00 |
| Jun 30, 2025 | -602,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 390,000.00 |
| Dec 31, 2024 | 390,000.00 |
| Sep 30, 2024 | -875,000.00 |
| Sep 30, 2024 | -875,000.00 |
| Jun 30, 2024 | 883,000.00 |
| Jun 30, 2024 | 883,000.00 |
| Mar 31, 2024 | -16,000.00 |
| Mar 31, 2024 | -16,000.00 |
| Dec 31, 2023 | 485,000.00 |
| Dec 31, 2023 | 485,000.00 |